Procaps Enters into Agreement with BDR Pharmaceuticals to Expand Oncology Portfolio in Latin America
Many of these molecules, if approved, will likely be introduced to our region for the first time," said Dr. Camilo Camacho, COO of Procaps Group.
Posted On October 18, 2023